Skip to content

Target Temperature Management In Myocardial Infarction - A Pilot Study

Target Temperature Management In Myocardial Infarction - A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01864343
Enrollment
19
Registered
2013-05-29
Start date
2011-09-30
Completion date
2013-05-31
Last updated
2013-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ST-elevation Myocardial Infarction

Keywords

Myocardial Infarction, Myocardial Reperfusion Injury, Reperfusion Injury, Anterior Wall Myocardial Infarction, Inferior Wall Myocardial Infarction, Myocardial Ischemia

Brief summary

The primary goal in the treatment of acute myocardial infarction is to reperfuse the ischemic myocardium to reduce infarct size. Animal data and human data suggest that whole-body cooling to temperatures below 35°C before revascularisation can additionally reduce infarct size and therefore improves outcome in these patients. The purpose of the study is to determine the feasibility and safety of a combined cooling strategy started in the out-of-hospital arena for achieving pre-reperfusion hypothermia in patients with acute st-elevation myocardial infarction.

Interventions

Surface cooling with EMCOOLS flex pads (out-of-hospital); Infusion of 1000ml to 2000ml of cold saline (out-of-hospital); central-venous cooling (Philips Innercool RTx)

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 and 75 years * Immediately transfer to cath-lab is possible * Anterior or inferior ST-Elevation myocardial infarction * ST-Segment elevation of \>0.2mV in 2 or more anatomically contiguous leads * Duration of symptoms \<6 hours

Exclusion criteria

* Participation in another study * Patients presenting with cardiac arrest * Tympanic temperature of \<35.0°C prior enrolment * Thrombolysis therapy * Previous myocardial infarction in medical history * Previous percutaneous coronary intervention or coronary artery bypass graft * Severe heart failure (defined as a New York Heart Association (NYHA) score of III or IV), Killip class II through IV at presentation * Clinical signs of infection * End-stage kidney disease or hepatic failure * Recent stroke (within the last six month) * Conditions that may be exacerbated by hypothermia, such as haematological dyscrasias, oral anticoagulant treatment with international normalized radio \>1.5, severe pulmonary disease * Pregnancy. Women of childbearing potential are excluded * Allergy to meperidine, buspirone, magnesium, or polyvinyl chloride * Use of a monoamine oxidase inhibitor such as selegiline in the previous 14 days

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of a combined cooling strategy for achieving a core temperature of <35.0°C at the time of reperfusion of the infarct related arteryTime of reperfusion of the culprit lesion in st-elevation myocardial infarction (expected average 120 minutes)Blood temperature will be recorded at the time of first wire-crossed lesion of the infarct related coronary stenosis

Secondary

MeasureTime frameDescription
Safety of a combined cooling strategy as an adjunctive therapy on primary percutaneous coronary intervention in acute st-elevation myocardial infarctionwithin 45 days (+/- 15 days)Incidence of major adverse cardiac events as defined as: death, heart failure, pulmonary edema, recurrent MI, malignant arrhythmias (i.e. ventricular fibrillation, sustained ventricular tachycardia) emergent stent revascularisation, any hospitalisation, major/minor bleeding (according to TIMI-bleeding score), infection (clinical relevant infection with the need of systemic antimicrobiotic therapy) within a period of 45±15 days
Tolerability of a combined cooling strategy as an adjunctive therapy on primary percutaneous coronary intervention in acute st-elevation myocardial infarctionduring active cooling and rewarming (in average the first 4 hours)Patients are monitored for incidence of shivering using a 4-point scale: 0, no shivering evident; 1, isolated facial or masticatory fasciculation; 2, peripheral shivering; 3, uncontrolled rigor during the cooling procedure (in average the first 4 hours)
Time to revascularisation (first medical contact to balloon time)Time of reperfusion (in average 120 minutes)The time to reperfusion of the infarct related artery is crucial in acute ST-elevation myocardial infarction. To evaluate if the cooling procedure has a substantial influence on this time frame we measure the time from first medical contact to reperfusion.

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026